Equipment for comprehensive treatment of facial and periorbital tissue.


It is a device that generates electromagnetic waves that consists of the application of a high frequency current that induces hyperthermia.

Our system has three particularities:

- Control of the energy dose by means of impulse trains adapted to the thermal relaxation times of the target structures to protect the effects on the surrounding tissues.

- Treatment depth control through the electrode positioning system to reach only the area to be treated.

- Proprietary MTO® (Multilayer Thermal Obstruction) technology to obtain the thermal effect only in the necessary areas.
Equipo RF para el tratamiento de la sequedad ocular-Infinity-rf


The two electrodes are designed to supply the energy of the Infinity RF System, in the exact area and with the necessary depth that we need for the optimization of the treatment. The treatment is carried out  for  3 phases, wpml_nbsp, following the indications of the screen. The two  heads are able to reach greater depth in the tissue efficiently and safely.

Epipalpebral area

The Infinity-RF Bipolar head is light and easy to use. It is specific for performing treatment in the epipalpebral area

Periorbital zone

With this four-pole head, we managed to deliver the energy transversally, due to the location of its poles and repairing it efficiently and safely.

Treating the source of dry eyes optimizes long-term results

Action mechanism

In this way, with radiofrequency we can treat the epithelial problems of the eye on the ocular surface, through two mechanisms that are synergistically enhanced.

The device is based on the combination of two mechanisms of action.

On the one hand, radiofrequency uses high-frequency electromagnetic waves to generate heat in the tissues, which can stimulate the meibomian glands in the eyelids. These glands produce a lipid layer that helps to keep tears on the surface of the eye and prevent tears from evaporating too quickly, thereby improving tear quality and reducing symptoms in the eye.

On the other hand, radiofrequency produces non-invasive transdermal neurological stimulation, achieving similar effects to intranasal neurostimulation. Increase the amount of the tear and restore its proper composition.

Neuromodulation through intranasal neurostimulation (use of electrical currents for neurological stimulation of the nasolacrimal reflex and increase the production, not only of tears, but also of mucin and meibum).

(Gabriela Dieckmann, Felipe Fregni, Pedram Hamrah, Neurostimulation in dry eye disease—past, present, and future, The Ocular Surface, Volume 17, Issue 1, 2019, Pages 20-27, ISSN 1542-0124)

(Darlene A. Dartt, Neural regulation of lacrimal gland secretory processes: Relevance in dry eye diseases, Progress in Retinal and Eye Research, Volume 28, Issue 3, 2009, Pages 155-177, ISSN 1350-9462)

Treatment protocol

The protocol is 6 initial sessions. There will be 1 session per week, for four consecutive weeks. The following month there will be a session every 15 days. Once these 6 sessions are over, one session per month will be held for 6 months. Although the sessions can be variable depending on the personal response.

It can be combined with pulsed light treatment to increase the speed of results and reduce the number of sessions needed.

Clinical results

Studies have been carried out in which an improvement in the quantity and quality of tears has been verified, after treatment, in 87% of cases.


Effective treatment in short sessions

Exclusion criteria

The treatment is contraindicated in the following cases.




Wounds and skin diseases in the area to be applied.


Use of pacemakers.


Caution in epileptic people where anxiety can trigger an attack.


Existence of metal prostheses in the area of application.


On moles or premalignant skin lesions.

Transcutaneous electrical stimulation has been shown to improve ED, both subjectively and objectively, without adverse effects and has the potential to broaden the armamentarium for ED treatment.


Monopolar Radiofrequency Treatment of the Eyelids: A Safety Evaluation

Brian S. Biesman, Md, Facs, and Karl Pope, M

High Frequency Electrotherapy for the Treatment of Meibomian Gland Dysfunction

Giulio Ferrari, MD, PhD,* Annalisa Colucci, MD,* Marco Barbariga, PhD,* Alfredo Ruggeri, PhD,†‡ and Paolo Rama, MD*
Scroll to Top